Projects per year
Personal profile
Education
- 2009 Honorary Doctor of Medicine, National Taiwan University, Taiwan
- 1989-1991 Fellow in Medical Oncology. Washington Hospital Center, Washington, D.C.
- 1970 Maryland Medical License
- 1961 ECFMG (Examining Council for Foreign Medical Graduates)
- 1959-1960 Resident in Pathology,Quincy City Hospital, Quincy, Mass.
- 1957-1959 Intern; Resident; Chief Resident in Surgery, New England Hospital, Boston, Massachusetts
- 1956 M.D. Medical College of Taiwan University, Taipei, Taiwan, R.O.C
- 1955-1957 Intern and Fixed Intern in Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
- Resident in Internal Medicine, George Washington University Hospital, Washington, D.C., Maryland
- Virginia Medical License
- Certification: Clinical Cytogenetics (American Board of Medical Genetics)
- Specialist in Internal Medicine, The Board of Physician Quality Assurance of the State of Maryland
- Bona Fide Member, Taipei Medical Association（12965）
- The Board of Medical Oncology of the Chinese Oncology Society (82014)
Experience
- Vice Dean, College of Medical Science and Technology, Taipei Medical University
- Superintendent, Taipei Cancer Center, Taipei Medical University
- 2017.05- Director, Taiwan Oncology Society, R.O.C.
- 2015.08- Director, Taiwan Lung Cancer Society, R.O.C.
- 2014.10- Board Member, Development Center for Biotechnology (DCB)
- 2014.06- Member of the Board of Supervisors, Taiwan Genomics and Genetic Society
- 2014.06- Board Member, The MJ Health Research Foundation
- 2013.08- Superintendent, Taipei Cancer Center, Taipei Medical University
- 2013.04- Member, The Tang Prize Selection Committee, Academia Sinica
- 2013.01- Board Member, National Health Research Institutes (NHRI)
- 2012- Member, Certificate Approval Committee, Quality improvement of cancer service, BHP, Minstry of Health and Welfare (MOHW)
- 2012- Member, Committee of Hepatitis and Liver Cancer Control and Prevention, MOHW
- 2012- Member, Council Unit of Policy of Chinese Medicine Industries, Committee on Chinese Medicine and Pharmacy, MOHW
- 2012- Member, Council Unit of Science and Technology, MOHW
- 2012- Member, Honorary Doctorate Program Review Committee, Taipei Medical University
- 2012- Member, United Biobank Management Committee, Taipei Medical University
- 2011- Deputy member, Human Subject Research Ethics Committee, Academia Sinica
- 2011- Chair Professor & Associate Dean, Medical Science & Technology College of Taipei Medical University
- 2010- General Director, Cancer Research Center, Taipei Medical University
- 2009- Honorary Vice Superintendent, Taipei Medical University-Shangho Hospital, MOHW
- 2009- Adjunct Professor, Graduate Institute of Oncology, National Taiwan University
- 2008- Distinguished Research Fellow, Taipei Veterans General Hospital, Taiwan
- 2008- Physician, Hematology & Oncology, Taipei Medical University-Municipal Wan Fang Hospital
- 1998- Member, Academic Review Committee Ministry of Education, Executive Yuan
- 1997- Vice President, Formosa Cancer Foundation
Awards
- 1968 Woman of the Year Award, ROC
- 1972 Arthur Flemming Award, USA
- 1972 Honor Award from Department of Health, Education and Welfare, USA
- 1984 Academician, Academia Sinica, ROC
- 1985 Member, Advisory Committee, Institute of Biomedical Sciences, Academia Sinica
- 1985 Scientific Award & President, Chinese American Medical and Health Asso., USA
- 1989 Scientific Award, Chinese American Medical Society of USA
- 1989 Outstanding Scientific Award, Organization of Chinese Americans, USA
- 1989 PHS Commendation Award, USA
- 1990-1995 Advisory Member, Institute of Biomedical Sciences, Academia Sinica
- 1991-2008 Honorary Consultant, Veterans General Hospital-Taipei
- 1992-1994 Advisory Member, Institute of Zoology, Academia Sinica
- 1993-1996 Honorary Consultant, National Taiwan University Hospital
- 1993-1998 Advisory Member, Atomic Energy Council, Executive Yuan
- 1994 Advisory Member, Institute of Molecular Biology, Academia Sinica
- 1994-1998 Outstanding Scholarship Lecturer, Foundation for the Advanced Outstanding Scholarship
- 1995 Review Member, Personnel Committee, National Health Research Institutes
- 1995-1998 Advisory Member, AIDS Consultation Committee, Department of Health, Executive Yuan
- 1995-1997 President, the Chinese Oncology Society
- 1996-2007 Review Member, Recruitment and Advisory Committee, National Health Research Institutes
- 1996-2007 Review Member, Recruitment and Advisory Committee, Biostatistic Research Division, National Health Research Institutes
- 1996 Review Member, Yang Investigators’ Thesis Award, Academia Sinica
- 1996 Review Member, Research Physicians Grant, Institute of Biomedical Sciences, Academia Sinica
- 1996-1999 President, the Chinese Society of Genetics
- 1996-2009 Adjunct Professor, Medical College, National Taiwan University
- 1998-2001 President, The Chinese Society of Clinical Oncology,
- 2001-2007 Jacqueline Whang-Peng Honorary Lecturer (彭汪嘉康榮譽獎座)，National Tsing Hua University
- 2004-2006 Councilor, the Central Cancer Control Meeting, Executive Yuan
- 2007-2010 Chang-Chin Lecturer National Tsing Hua University
- 2008 Award for 1st L’OREAL Women for Science, Taiwan
- 2008 Distinguished Investigator, Emeritus, National Health Research Institutes
- 2009 Honorary Doctor of Medicine, National Taiwan University
- 2011 The 2011 Reach to Recovery International Health Professional Medal, UICC
- 2015 COS Lifetime Achievement Award, the Chinese Oncology Society, R.O.C
- 2015 Health Medal of the First Order, Ministry of Health and Welfare, R.O.C.
Research Interests
- Hemato-oncology
- Oncogenetics
Fingerprint
Dive into the research topics where Jacqueline Whang-Peng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
To Establish Clinical Connection of Integrin Αvβ3-Network and Ceacam6 as Progressing Detection Biomarkers and Therapeutic Targets in Cholangiocarcinoma Patient.( II )
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
標靶整合素αvβ3-FAK訊號網絡的膽管癌診療策略開發-基於整合素αvβ3和CEACAM6的訊號網絡建立膽管癌患者的診斷生物標記與治療標靶之臨床連結(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
奈米HEVnp於晚期大腸直腸癌患者的治療策略(3/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
奈米HEVnp於晚期大腸直腸癌患者的治療策略(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Nano-Hevnp Theranostic Strategy for Late-Stage Colorectal Cancer Patients(1/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-Glucoside improves female ovarian aging
Lin, H. Y., Yang, Y. N., Chen, Y. F., Huang, T. Y., Crawford, D. R., Chuang, H. Y., Chin, Y. T., Chu, H. R., Li, Z. L., Shih, Y. J., Chen, Y. R., Yang, Y. C. S. H., Ho, Y., Davis, P. J., Whang-Peng, J. & Wang, K., Aug 30 2022, In: Frontiers in Cell and Developmental Biology. 10, 862045.Research output: Contribution to journal › Article › peer-review
Open Access -
Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition
Chung, C. C., Huang, T. Y., Chu, H. R., De Luca, R., Candelotti, E., Huang, C. H., Yang, Y. C. S. H., Incerpi, S., Pedersen, J. Z., Lin, C. Y., Huang, H. M., Lee, S. Y., Li, Z. L., ChangOu, C. A., Li, W. S., Davis, P. J., Lin, H. Y., Whang-Peng, J. & Wang, K., Mar 2022, In: Food and Chemical Toxicology. 161, 112850.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus) -
Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells
Unson, S., Chang, T-C., Yang, Y. N., Wang, S. H., Huang, C. H., Crawford, D. R., Huang, H-M., Li, Z. L., Lin, H. Y., Whang-Peng, J., Kuan, W., Davis, P. J. & Li, W. S., Jul 27 2022, In: Marine Drugs. 20, 8, 482.Research output: Contribution to journal › Article › peer-review
Open Access -
Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer Cells
Chen, Y. F., Yang, Y. N., Chu, H. R., Huang, T. Y., Wang, S. H., Chen, H. Y., Li, Z. L., Yang, Y. C. S. H., Lin, H. Y., Hercbergs, A., Whang-Peng, J., Wang, K. & Davis, P. J., Feb 14 2022, In: Frontiers in Cell and Developmental Biology. 10, 829788.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Selenium Yeast and Fish Oil Combination Diminishes Cancer Stem Cell Traits and Reverses Cisplatin Resistance in A549 Sphere Cells
Lai, I. C., Liao, C. H., Hu, M. H., Chang, C. L., Lai, G. M., Chiou, T. J., Hsia, S., Tsai, W. L., Lin, Y. Y., Chuang, S. E., Whang-Peng, J., Chen, H. Y. & Yao, C. J., Aug 2022, In: Nutrients. 14, 15, 3232.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Whang-Peng, J. (Creator), Chow, J. (Contributor), Yan, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Creator), Lai, I. (Contributor), Yao, C. (Contributor), Lai, G. (Contributor), Bai, K. (Contributor), Chuang, S. (Contributor) & Li, C. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d3.v1
Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Creator), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Creator), Bai, K. (Contributor) & Yao, C. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, G. (Contributor), Li, C. (Contributor), Yeh, C. (Creator), Whang-Peng, J. (Creator), Lee, H. (Contributor), Yao, C. (Contributor), Lai, I. (Contributor), Chuang, S. (Contributor), Chow, J. (Contributor), Bai, K. (Contributor) & Yan, J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d1.v1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Chuang, S. (Contributor), Lai, I. (Contributor), Yeh, C. (Creator), Yan, J. (Contributor), Yao, C. (Contributor), Whang-Peng, J. (Creator), Li, C. (Contributor), Chow, J. (Contributor), Bai, K. (Contributor), Lee, H. (Contributor) & Lai, G. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d2.v1
Dataset
-
Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction
Huang, J. (Contributor), Yao, C. (Contributor), Chuang, S. (Contributor), Yeh, C. (Contributor), Lee, L. (Creator), Chen, R. (Contributor), Chao, W. (Contributor), Whang-Peng, J. (Creator) & Lai, G. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3643112.v1, https://figshare.com/collections/Honokiol_inhibits_sphere_formation_and_xenograft_growth_of_oral_cancer_side_population_cells_accompanied_with_JAK_STAT_signaling_pathway_suppression_and_apoptosis_induction/3643112/1
Dataset